KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,027 | -81.7% | 2,212 | -76.5% | 0.07% | -82.1% |
| Q2 2023 | $2,044,245 | -12.8% | 9,427 | -27.0% | 0.40% | -16.1% |
| Q1 2023 | $2,344,427 | -33.9% | 12,907 | -28.5% | 0.47% | -34.2% |
| Q4 2022 | $3,547,808 | +3.5% | 18,055 | +18.5% | 0.72% | +1.8% |
| Q3 2022 | $3,428,000 | +36.0% | 15,239 | -23.5% | 0.71% | +42.6% |
| Q2 2022 | $2,520,000 | +111.1% | 19,920 | +100.6% | 0.50% | +187.8% |
| Q1 2021 | $1,194,000 | -39.5% | 9,929 | -48.8% | 0.17% | -45.9% |
| Q4 2020 | $1,972,000 | -17.7% | 19,407 | -37.3% | 0.32% | -36.5% |
| Q3 2020 | $2,395,000 | -29.1% | 30,970 | +2.2% | 0.50% | -30.2% |
| Q2 2020 | $3,377,000 | +81.5% | 30,298 | +17.2% | 0.72% | +27.8% |
| Q1 2020 | $1,861,000 | -4.3% | 25,844 | +0.2% | 0.56% | +40.9% |
| Q4 2019 | $1,944,000 | – | 25,804 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |